Home » Topics » Regulatory » Patents

Patents
RSS

Tsumura team reveals semisynthetic huperzine derivatives

Jan. 29, 1998

More new agents for influenza from Lilly

Jan. 29, 1998

Meiji Seika describes 5-HT3 partial agonists for GI disorders

Jan. 29, 1998

New excitatory amino acid antagonists in development at Pfizer

Jan. 29, 1998

Inhibitors of the production or release of sCD23, TNF

Jan. 29, 1998

Dopamine D4 receptor antagonists for imaging and therapy disclosed by Janssen

Jan. 29, 1998

BMS discloses new Taxol derivative

Jan. 28, 1998

Phenylglycine derivatives with mGluR-antagonist activity disclosed by Lilly

Jan. 28, 1998

Flavopiridol analogues as inhibitors of cyclin-dependent kinases

Jan. 28, 1998

Antitumor and antiviral distamycin derivatives from Pharmacia & Upjohn

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...